Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production

Por Khanim, F L, Merrick, B A M E, Giles, H V, Jankute, M, Jackson, J B, Giles, L J, Birtwistle, J, Bunce, C M, Drayson, M T
Publicado em 2011